Liver Disease Flashcards
BBW for all DAAs
risk of reactivating HBV
Mayvret
glecaprevir/pibrentasvir
Epclusa
sofosbuvir/velpatasvir
Harvoni
sofosbuvir/ledipasvir
Vosevi
sofosbuvir/velpatasvir/voxilaprevir
Zepatier
elbasvir/grazoprevir
HCV treatments approved for all HCV genotypes
Epclusa, Mayvret
HCV treatment approved for 8 week course
Mayvret
HCV treatment approved for salvage therapy
Vosevi and Mayvret
DAAs are CI’ed with what?
CYP3A4 inducers
When can ribavirin be used in HCV?
Add-on treatment to DAAs
BBW for ribavirin
teratogenicity, hemolytic anemia, not effective as monotherapy
CIs for ribavirin
pregnancy, male partners of pregnant women
When to avoid pregnancy when taking ribavirin
during therapy and 6 months after; use 2 reliable forms of contraception
BBW for all HBV NRTIs
lactic acidosis and severe hepatomegaly with steatosis